Bone Therapeutics Gains Funding for Tissue Engineered Bone Implants

Bone Therapeutics and partners Cerhum, 3D-Side, mSKIL and IREC received €3 million (~USD $3.5 million) to support TrueBone3D, a new research collaboration developing biologically active, patient-tailored, 3D-printed, bioresorbable implants enriched with Bone Therapeutics’ ALLOB allogeneic bone forming cells.

This 28-month collaboration seeks...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us